Cancer Causes & Control

, Volume 17, Issue 4, pp 459–467

Relation of Anthropometric Measurements to Ovarian Cancer Risk in a Population-based Case–control Study (United States)

  • Neeraja B. Peterson
  • Amy Trentham-Dietz
  • Polly A. Newcomb
  • Zhi Chen
  • Tebeb Gebretsadik
  • John M. Hampton
  • Meir J. Stampfer
  • Walter C. Willett
  • Kathleen M. Egan
Original Paper

Abstract

Objective

To examine the relationship between anthropometric measures and ovarian cancer by menopausal status.

Methods

We analyzed data from a population-based case–control study comprised of 700 incident cases of epithelial ovarian cancer and 5,943 population controls from Massachusetts and Wisconsin enrolled between 1993 and 2001. In a telephone interview, information was gathered on established ovarian cancer risk factors, as well as adult height and age-specific body weight. Logistic regression was used to estimate multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for body mass index (BMI) throughout life.

Results

Recent BMI had no significant association with ovarian cancer risk (P-trend 0.14 for continuous BMI), after adjustment for age and other ovarian cancer risk factors. However, a non-significant positive association (overall P-trend 0.08) was observed for BMI at age 20; the risk estimate comparing a body mass of >25 kg/m2 to the lowest quintile (≤18.88 kg/m2) was moderately but non-significantly elevated (OR 1.46; 95% CI 0.92, 2.31).

Conclusion

Results of this study suggest that maintenance of a lean body mass, particularly in early adult life, may decrease ovarian cancer risk.

Keywords

Ovarian neoplasms Body mass index Obesity Risk factors Menopause 

References

  1. 1.
    Jemal A, Murray T, Ward E et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30PubMedGoogle Scholar
  2. 2.
    Anonymous (2002) Cancer incidence in five continents, vol VIII. IARC Sci Publ 1-781Google Scholar
  3. 3.
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638CrossRefPubMedGoogle Scholar
  4. 4.
    Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE (1979) “Incessant ovulation” and ovarian cancer. Lancet 2:170–173PubMedGoogle Scholar
  5. 5.
    Cramer DW, Welch WR, Hutchison GB, Willett W, Scully RE (1984) Dietary animal fat in relation to ovarian cancer risk. Obstet Gynecol 63:833–838PubMedGoogle Scholar
  6. 6.
    Farrow DC, Weiss NS, Lyon JL, Daling JR (1989) Association of obesity and ovarian cancer in a case–control study. Am J Epidemiol 129:1300–1304PubMedGoogle Scholar
  7. 7.
    Purdie D, Green A, Bain C et al. (1995) Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case–control study. Survey of Women’s Health Study Group. Int J Cancer 62:678–684PubMedGoogle Scholar
  8. 8.
    Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ (2002) Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 11:822–8PubMedGoogle Scholar
  9. 9.
    Hoyo C, Berchuck A, Halabi S et al. (2005) Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women. Cancer Causes Control 16:955–963CrossRefPubMedGoogle Scholar
  10. 10.
    Schouten LJ, Goldbohm RA, van den Brandt PA (2003) Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157:424–433CrossRefPubMedGoogle Scholar
  11. 11.
    Annegers JF, Strom H, Decker DG, Dockerty MB, O’Fallon WM (1979) Ovarian cancer: incidence and case–control study. Cancer 43:723–729PubMedGoogle Scholar
  12. 12.
    Engeland A, Tretli S, Bjorge T (2003) Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 95:1244–1248PubMedGoogle Scholar
  13. 13.
    Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE (2002) Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100:288–296CrossRefPubMedGoogle Scholar
  14. 14.
    Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ (1989) A case–control study of epithelial ovarian cancer. Am J Obstet Gynecol 161:10–16PubMedGoogle Scholar
  15. 15.
    Mink PJ, Folsom AR, Sellers TA, Kushi LH (1996) Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: a follow-up study of older women. Epidemiology 7:38–45PubMedGoogle Scholar
  16. 16.
    Lukanova A, Toniolo P, Lundin E et al. (2002) Body mass index in relation to ovarian cancer: a multi-centre nested case–control study. Int J Cancer 99:603–608CrossRefPubMedGoogle Scholar
  17. 17.
    Parazzini F, Moroni S, La Vecchia C, Negri E, dal Pino D, Bolis G (1997) Ovarian cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 33:1634–1637CrossRefPubMedGoogle Scholar
  18. 18.
    Kuper H, Cramer DW, Titus-Ernstoff L (2002) Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control 13:455–463CrossRefPubMedGoogle Scholar
  19. 19.
    Hunter DJ, Willett WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15:110–132PubMedGoogle Scholar
  20. 20.
    Trentham-Dietz A, Newcomb PA, Storer BE et al. (1997) Body size and risk of breast cancer. Am J Epidemiol 145:1011–1019PubMedGoogle Scholar
  21. 21.
    Huang Z, Hankinson SE, Colditz GA et al. (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407–1411PubMedGoogle Scholar
  22. 22.
    Morimoto LM, White E, Chen Z et al. (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control 13:741–751CrossRefPubMedGoogle Scholar
  23. 23.
    Trentham-Dietz A, Newcomb PA, Egan KM et al. (2000) Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11:533–542CrossRefPubMedGoogle Scholar
  24. 24.
    Breslow NE DNE (1980) Statistical methods in cancer research, vol 1. The analysis of case–control studies. International Agency for Research on CancerGoogle Scholar
  25. 25.
    Willett W (1998) Nutritional epidemiology. Oxford University Press, New YorkGoogle Scholar
  26. 26.
    Michels KB, Greenland S, Rosner BA (1998) Does body mass index adequately capture the relation of body composition and body size to health outcomes? Am J Epidemiol 147:167–172PubMedGoogle Scholar
  27. 27.
    Dal Maso L, Franceschi S, Negri E et al. (2002) Body size indices at different ages and epithelial ovarian cancer risk. Eur J Cancer 38:1769–1774CrossRefPubMedGoogle Scholar
  28. 28.
    Jordan SJ, Webb PM, Green AC (2005) Height, age at menarche, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 14:2045–2048CrossRefPubMedGoogle Scholar
  29. 29.
    Anderson JP, Ross JA, Folsom AR (2004) Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women’s Health Study. Cancer 100:1515–1521CrossRefPubMedGoogle Scholar
  30. 30.
    Lubin F, Chetrit A, Freedman LS et al. (2003) Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 157:113–120CrossRefPubMedGoogle Scholar
  31. 31.
    Anonymous (2002) IARC working group on the evaluation of cancer-preventive strategies: weight control and physical activity. IARC Press, Lyon, FranceGoogle Scholar
  32. 32.
    van den Brandt PA, Spiegelman D, Yaun SS et al. (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152:514–527PubMedGoogle Scholar
  33. 33.
    Key TJ, Allen NE, Verkasalo PK, Banks E (2001) Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 60:81–89PubMedGoogle Scholar
  34. 34.
    Bjorntorp P (1997) Obesity. Lancet 350:423–426CrossRefPubMedGoogle Scholar
  35. 35.
    Key TJ, Appleby PN, Reeves GK et al. (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218–1226PubMedGoogle Scholar
  36. 36.
    Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88:756–758PubMedGoogle Scholar
  37. 37.
    Hankinson SE, Willett WC, Manson JE et al. (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90:1292–1299CrossRefPubMedGoogle Scholar
  38. 38.
    Dale PO, Tanbo T, Vaaler S, Abyholm T (1992) Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril 58:487–491PubMedGoogle Scholar
  39. 39.
    Wajchenberg BL, Marcondes JA, Mathor MB, Achando SS, Germak OA, Kirschner MA (1989) Free testosterone levels during the menstrual cycle in obese versus normal women. Fertil Steril 51:535–537PubMedGoogle Scholar
  40. 40.
    Wu S, Donigan A, Platsoucas CD, Jung W, Soprano DR, Soprano KJ (1997) All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1. Exp Cell Res 232:277–286CrossRefPubMedGoogle Scholar
  41. 41.
    Nestler JE (2000) Obesity, insulin, sex steroids and ovulation. Int J Obes Relat Metab Disord 24(Suppl 2):S71–S73PubMedGoogle Scholar
  42. 42.
    Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90:1774–1786CrossRefPubMedGoogle Scholar
  43. 43.
    Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM (2001) Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res 61:6768–6776PubMedGoogle Scholar
  44. 44.
    Silva EG, Tornos C, Fritsche HA Jr et al. (1997) The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod Pathol 10:879–883PubMedGoogle Scholar
  45. 45.
    Slotman BJ, Rao BR (1989) Response to inhibition of androgen action of human ovarian cancer cells in vitro. Cancer Lett 45:213–220CrossRefPubMedGoogle Scholar
  46. 46.
    Cardillo MR, Petrangeli E, Aliotta N et al. (1998) Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. J Exp Clin Cancer Res 17:231–237PubMedGoogle Scholar
  47. 47.
    Murphy A, Cropp CS, Smith BS, Burkman RT, Zacur HA (1990) Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women. Fertil Steril 53:35–39PubMedGoogle Scholar
  48. 48.
    Kuhnz W, Sostarek D, Gansau C, Louton T, Mahler M (1991) Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum. Am J Obstet Gynecol 165:596–602PubMedGoogle Scholar
  49. 49.
    van d V, Blankenstein MA, Kloosterboer HJ, Haspels AA, Thijssen JH (1990) Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception 41:345–352Google Scholar
  50. 50.
    Helzlsouer KJ, Alberg AJ, Gordon GB et al. (1995) Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 274:1926–1930CrossRefPubMedGoogle Scholar
  51. 51.
    Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C (1996) Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88:554–559CrossRefPubMedGoogle Scholar
  52. 52.
    Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331:771–776CrossRefPubMedGoogle Scholar
  53. 53.
    Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case–control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136:1184–1203PubMedGoogle Scholar
  54. 54.
    Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ (1988) Accuracy and reliability of self-measurement of body girths. Am J Epidemiol 128:740–748PubMedGoogle Scholar
  55. 55.
    Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466– 473PubMedGoogle Scholar
  56. 56.
    Stewart AL (1982) The reliability and validity of self-reported weight and height. J Chronic Dis 35:295–309CrossRefPubMedGoogle Scholar
  57. 57.
    Stewart AW, Jackson RT, Ford MA, Beaglehole R (1987) Underestimation of relative weight by use of self-reported height and weight. Am J Epidemiol 125:122–126PubMedGoogle Scholar
  58. 58.
    Stunkard AJ, Albaum JM (1981) The accuracy of self-reported weights. Am J Clin Nutr 34:1593–1599PubMedGoogle Scholar
  59. 59.
    Lawlor DA, Bedford C, Taylor M, Ebrahim S (2002) Agreement between measured and self-reported weight in older women. Results from the British Women’s Heart and Health Study. Age Ageing 31:169–174CrossRefPubMedGoogle Scholar
  60. 60.
    Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC (1995) The validity of recalled weight among younger women. Int J Obes Relat Metab Disord 19:570–572PubMedGoogle Scholar
  61. 61.
    Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF (1995) The validity of self-reports of past body weights by U.S. adults. Epidemiology 6:61–66PubMedGoogle Scholar
  62. 62.
    Villanueva EV (2001) The validity of self-reported weight in US adults: a population based cross-sectional study. BMC Public Health 1:11CrossRefPubMedGoogle Scholar
  63. 63.
    Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S (1989) The predictive validity of body mass index based on self-reported weight and height. Int J Obes 13:441–453PubMedGoogle Scholar
  64. 64.
    Kuskowska-Wolk A, Bergstrom R, Bostrom G (1992) Relationship between questionnaire data and medical records of height, weight and body mass index. Int J Obes Relat Metab Disord 16:1–9PubMedGoogle Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  • Neeraja B. Peterson
    • 1
  • Amy Trentham-Dietz
    • 1
  • Polly A. Newcomb
    • 1
  • Zhi Chen
    • 1
  • Tebeb Gebretsadik
    • 1
  • John M. Hampton
    • 1
  • Meir J. Stampfer
    • 1
  • Walter C. Willett
    • 1
  • Kathleen M. Egan
    • 1
  1. 1.Department of Medicine, Division of General Internal Medicine and Public HealthVanderbilt University School of MedicineNashvilleUSA

Personalised recommendations